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ABSTRACT
Many RNA-binding proteins including a master reg-
ulator of splicing in developing brain and muscle,
polypyrimidine tract-binding protein 1 (PTBP1), can
either activate or repress alternative exons depend-
ing on the pre-mRNA recruitment position. When
bound upstream or within regulated exons PTBP1
tends to promote their skipping, whereas binding to
downstream sites often stimulates inclusion. How
this switch is orchestrated at the molecular level
is poorly understood. Using bioinformatics and bio-
chemical approaches we show that interaction of
PTBP1 with downstream intronic sequences can acti-
vate natural cassette exons by promoting productive
docking of the spliceosomal U1 snRNP to a subop-
timal 5′ splice site. Strikingly, introducing upstream
PTBP1 sites to this circuitry leads to a potent splicing
repression accompanied by the assembly of an ex-
onic ribonucleoprotein complex with a tightly bound
U1 but not U2 snRNP. Our data suggest a molecu-
lar mechanism underlying the transition between a
better-known repressive function of PTBP1 and its
role as a bona fide splicing activator. More generally,
we argue that the functional outcome of individual
RNA contacts made by an RNA-binding protein is
subject to extensive context-specific modulation.
INTRODUCTION
Alternative pre-mRNA splicing expands protein diversity
and gene regulation possibilities in eukaryotes through non-
uniform utilization of exons and introns (1–4). It is exten-
sively controlled by interactions betweenRNA-encoded cis-
elements and cognate RNA-binding proteins (RBPs) (5–9).
Many RBPs can either activate or repress splicing
depending on their binding position relative to a reg-
ulated exon (10–12). For example, transcriptome-wide
crosslinking-immunoprecipitation (CLIP) studies com-
bined with systematic analyses of splicing patterns showed
that RBPs from the NOVA family often repress alterna-
tive exons when recruited to an upstream intronic position
or the exon itself and promote their inclusion into mature
mRNA when bound downstream (13,14). Correlation of
upstream binding with repression and downstream binding
with activation of alternative exons has been shown for sev-
eral otherRBPs including those from theRbfox,Mbnl, Celf
and Esrp families and possibly hnRNP L (15–22). Similar
effects have been observed in minigene experiments relying
on a recombinant tethering approach (23).
Two distinct possibilities may account for these molec-
ular trends. An RBP can function invariantly, as a consti-
tutive repressor or activator, but have opposite effects on
different pre-mRNAs by targeting either regulated exons
themselves or their splicing competitors. This mechanism
has in fact been proposed to underlie at least a subset of
position-specific splicing events (24,25). Alternatively, an
RBP may repress some alternative exons and activate oth-
ers in a direct manner, suggesting a possibility of a genuine
switch between the two regulationmodes. Possible contribu-
tion of this mechanism to splicing regulation has not been
investigated systematically.
Polypyrimidine tract-binding protein 1 (PTBP1/PTB/hn
RNP I) is an important example of a position-specific reg-
ulator of alternative splicing that targets a large number of
transcripts in developing brain and muscle (12,26,27). Sim-
ilar to the examples above, PTBP1 binding immediately up-
stream of or within a regulated exon correlates with skip-
ping whereas recruitment to a downstream position tends
to promote inclusion (25,28,29). Mechanistically, PTBP1
binding upstream of or within an exon can inhibit produc-
tive association of the core splicing factors U2 snRNP and
U2AF with the branch point and the pyrimidine tract, re-
spectively (30,31). At least in some cases, this may involve
PTBP1-mediated repression of exon definition interactions
(32).
How downstream recruitment stimulates inclusion of the
regulated exon is understood to a substantially lesser ex-
tent. When bound to sufficiently distant intronic positions,
PTBP1 may inhibit a downstream constitutive exon thus
giving the regulated exon a competitive advantage (12,25).
Conversely, PTBP1 recruited immediately downstream of a
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cassette exon or an alternative 5′ splice site (5’ss) has been
proposed to activate them directly (28,33). However, the
molecular mechanism underlying this hypothetical activity
is unknown.
Our understanding of the PTBP1-dependent ‘splicing
code’ is further complicated by recurring examples where
PTBP1 promotes skipping of alternative exons by form-
ing contacts with both upstream and downstream intronic
sequences (34,35). Several models have been proposed to
explain this effect including looping, lateral spreading of
PTBP1 oligomers, recruitment of co-repressors or/and for-
mation of unproductive splicing complexes (34–40). How
these molecular events might relate to PTBP1-mediated
splicing activation remains an open question.
Here we combine bioinformatics and experimental ap-
proaches to uncover a mechanism that allows PTBP1 to ac-
tivate alternative exons in a direct manner. Our data also
explain how recruitment of this protein both upstream and
downstream of a regulated exon can cancel out the activa-
tion effect and lead to repression.
MATERIALS AND METHODS
Plasmids
AdML-M3 plasmid encoding an adenovirus-derived splic-
ing substrate was a gift from Robin Reed (Addgene;
#11244). U1-encoding expression vector pN/S6U1 was de-
scribed earlier (41). New constructs were generated us-
ing standard molecular cloning techniques and enzymes
from NEB, as described in Supplementary Table S3. Site-
specific mutagenesis was done using KAPA HiFi DNA
polymerase (KAPA Biosystems) and corresponding muta-
genic primers (Supplementary Table S4). The plasmidmaps
and sequences are available on request.
Cell cultures
CADmouse neuroblastoma cells (42) were cultured in Dul-
becco’s Modified Eagle Medium/High Glucose (DMEM;
Thermo Fisher Scientific/GIBCO), supplemented with
11% FetalClone III Serum (GE Healthcare/HyClone), 1
mM sodium pyruvate (Thermo Fisher Scientific/GIBCO),
100 IU/ml penicillin and 100 g/ml streptomycin, at 37◦C
in the presence of 5% CO2. For transfection experiments,
cells were plated in the CAD medium without antibi-
otics at a density of 4 × 105 cells per well of a six-well
plate for tissue culture. Twelve hours post-plating, cells
were transfected with corresponding ON-TARGETplus
siRNA (GEHealthcare/Dharmacon; siControl [D-001810-
01-20]; siPtbp1 [J-042865-11-0050]; siPtbp2 [L-049626-01-
0005]) using Lipofectamine RNAiMAX (Thermo Fisher
Scientific/Invitrogen). Following 36-hour incubation, cell
cultures were typically re-transfected with 1 g of a mini-
gene plasmid using Lipofectamine 2000 and incubated for
another 36 h prior to RNA harvest. For U1 snRNA sup-
pressor experiments, the ratio of pN/S6U1 plasmid tomini-
gene plasmid used for transfections is 9:1. Neurons, neu-
ronal progenitor cells and astrocytes were isolated from
mouse cortices and maintained as described elsewhere (43).
RT-PCR and RT-qPCR
Total RNA was harvested from adherent cells using Tri-
zol (Thermo Fisher Scientific/Invitrogen). RNAwas subse-
quently treated with 50 units/ml of RQ1 DNase (Promega)
at 37◦C for 1 h to eliminate traces of genomic DNA. First-
strand cDNA synthesis (RT) was typically performed in
10 l reactions containing 2.5 g of total RNA, 50 pmol
of a random decamer primer (N10), 40 units of rRNAsin
(Promega) and 100 units of SuperScript III reverse tran-
scriptase (Thermo Fisher Scientific/Invitrogen) at 50◦C for
1 h. Regular PCRs were carried out using Taq DNA poly-
merase (KAPA Biosystems) and amplification products
were resolved by gel electrophoresis in 2% agarose gels.
Quantitative PCR (qPCR) assays were done in triplicate us-
ing SYBR® FAST qPCRMaster Mix (KAPA Biosystems)
and a StepOnePlus real-time PCR system (Applied Biosys-
tems) and the signals were normalized to Gapdh mRNA
levels. All primer sequences are provided in Supplementary
Table S4.
In vitro RNA synthesis using T7 RNA polymerase
DNA templates were obtained by either linearizing T7
promoter-containing plasmids with appropriate restriction
enzymes or by PCR amplification of gene fragments using
forward primers containing a 5′-terminal T7 promoter over-
hang. Unlabeled RNA substrates were prepared by tran-
scribing the DNAs in 25 l reactions containing 30 units of
T7 RNA polymerase, 10 mMDTT, 0.8 mMRibo m7G Cap
Analog, rNTP capping mix [0.5 mM rATP, 0.5 mM rCTP,
0.5 mM rUTP and 0.2 mM rGTP], 20 units of rRNAsin
for 2 h at 37◦C (all reagents from Promega). To generate
radiolabeled RNA fragments, we replaced 0.48 mM rUTP
with 20 Ci 32P-UTP (Perkin Elmer; NEG007X250UC).
Biotin-labeled RNA baits were prepared by replacing the
rNTP capping mix and Ribo m7G Cap Analog with the bi-
otin RNA labeling mix (Roche). Reactions were stopped by
adding 1 unit of RQ1 DNase (Promega) per 1 g of tem-
plate DNA and incubating the mixtures at 37◦C for an ad-
ditional 15 min. RNAs were then extracted using phenol-
chloroform (1:1) mixture, precipitated with ethanol and re-
hydrated in DEPC-treated water.
In vitro splicing assays
Splicing reactions were carried out as described (33).
In some experiments, we used a nuclear extract im-
munodepleted for PTBP1. For this purpose, 40 g of
mouse monoclonal anti-PTBP1 antibody (Thermo Fisher
Scientific/Invitrogen; clone 1) was incubated with 40 l
of protein G Sepharose beads (GE Healthcare) at 4◦C
overnight with continuous agitation. Beads were subse-
quently washed three times with buffer D (20 mMHEPES,
pH 7.9, 100 mM KCl, 20% glycerol, 0.5 mM DTT and
0.2 mM EDTA) and incubated with 50 l of HeLa S3 nu-
clear extract (pre-dialyzed against buffer D) for another 4 h
at 4◦C with agitation. The PTBP1-depleted nuclear extract
was then recovered by pelleting the beads at 3000 rpm for 2
min.
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Pull-down assays
Pull-down assays were carried out by incubating 2 g of bi-
otinylated RNA baits in 400 l of binding buffer (20 mM
HEPES–KOH, pH 7.5, 100mMKCl, 10mMMgCl2, 0.01%
Nonidet P-40 and 1 mM DTT) supplemented with 500 g
HeLa S3 nuclear extract (pre-dialyzed against buffer D)
for 1 h at room temperature. RNA-protein complexes were
then incubated with 30 l of Streptavidin Sepharose Beads
(Sigma) pre-washed in washing buffer (20 mM HEPES–
KOH, pH 7.5, 200 mM KCl, 10 mM MgCl2, 0.01% Non-
idet P-40 and 1 mMDTT) and pre-blocked with 0.2 mg/ml
BSA for 1 h in 4◦C. The beads were then washed three times
with washing buffer and the RNA-associated proteins were
eluted by boiling the beads for 10 min in 30 l of 1 × SDS
PAGE sample buffer (0.0625 M Tris–HCl pH 6.8, 2% SDS,
5%-mercaptoethanol, 10% glycerol and 0.01%bromophe-
nol blue) and subsequently analyzed by immunoblotting.
To isolate the RNA fraction, beads were incubated with
250 l of denaturation buffer (20 mMTris–HCl, 4 MUrea,
0.5% SDS, 10 mM EDTA, 0.3 M NaCl) at 37◦C for 10 min
followed by phenol–chloroform extraction and RNA pre-
cipitation.
RNase H protection assays
Forty thousand cpm of radiolabeled RNA was prein-
cubated in 20 l splicing mixtures for 15 min at
30◦C, supplemented with 75 pmol of a DNA oligonu-
cleotide complementary to the natural Dtx2 e6 5′ss
(5′-CACAACTACCTTTT-3) or its 5′G4A variant (5′-
CACAATTACCTTTT-3′) and 0.5 units of RNase H
(NEB). The incubation was continued at 30◦C for 15
min followed by phenol-chloroform extraction and RNA
precipitation. In some samples, nuclear extract was pre-
incubated with 75 pmol of the U1 antisense 2’OMe-RNA
(5′-UGCCAGGUAAGUAU-3′) at 30◦C for 10 min prior to
adding labeled RNAs. Cleaved RNA products were sepa-
rated by 6% denaturing polyacrylamide gel electrophoresis
and visualized using a using a Typhoon Trio phosphorim-
ager (GE Healthcare).
Immunoblotting
Proteins were extracted from PBS-washed adherent cells
using NP40 buffer [20 mM Tris–HCl, pH 7.5, 150 mM
NaCl, 5 mM EDTA, 10% glycerol, 1% Nonidet P-40, 1
mMphenylmethanesulfonyl fluoride and cOmplete EDTA-
free protease inhibitor cocktail (Roche; one tablet per 50
ml)] and quantified using a BCA protein assay kit (Thermo
Scientific). Proteins were then separated by 4–20% gradi-
ent SDS-PAGE (Bio-Rad), electrotransferred to nitrocel-
lulose membranes and analyzed using the following pri-
mary antibodies: mouse monoclonal anti-PTBP1 (1:1000;
Thermo Fisher Scientific/Invitrogen), mouse monoclonal
anti-PTBP2 (1:20 000; a gift from R. Darnell), mouse mon-
oclonal anti-U1-70K (1:1000; a gift from T. Maniatis),
mouse monoclonal anti-Gapdh (1:10 000; Thermo Fisher
Scientific/Ambion). Immunoblot signals were visualized
using corresponding secondary antibodies conjugated with
horseradish peroxidase (GE Healthcare) and Immobilon
Western Chemiluminescent HRP Substrate (EMD Milli-
pore).
Bioinformatics
CADcells treatedwith siControl, siPtbp1 or siPtbp1/2were
analyzed by RNA-seq as described [(44); NCBI GEO ac-
cession number GSE37933]. Alternative splicing changes
were quantified using ExpressionPlot (45) and cassette ex-
ons consistently up- or down-regulated in both siPtbp1 and
siPtbp1/2 samples compared to the siControl (P < 0.01)
were shortlisted for further analyses. Genes with >1 exon
regulated in response to siPtbp1 or siPtbp2 were omitted.
The 5′ss and 3′ss sequences were analyzed by MaxEntScan
andWebLogo (46,47) using internal constitutive exons from
PTBP1/2-regulated transcripts as controls. Exonic splicing
enhancers and silencers were predicted using the FIMO
program from the MEME suite (48) based on published
position weight matrices (49–51). Matches with P < 0.005
were used for further analyses. To detect motif enrichment
in intronic sequences preceding and following regulated ex-
ons, we computed GC-compensated average motif affinity
(AMA) P-values for the PTBP1/2-specific position weight
matrix [M227 from the CisBP-RNA database; (52)] using
the MEME suite. Sequences with P < 0.05 following the
Benjamini-Hochberg adjustment for multiple testing were
considered enriched for PTBP1/2 interaction motifs.
RESULTS
Characteristic features of mouse alternative exons activated
by PTBP1
In search for a mechanism that might allow PTBP1 to
function as a bona fide splicing activator we examined
cassette exons consistently up- and down-regulated upon
knocking down this RBP alone (siPtbp1) or together with
its functionally similar paralog PTBP2 (27) (siPtbp1/2)
in the mouse neuroblastoma cell line CAD (Supplemen-
tary Tables S1 and S2; see Materials and Methods). In
line with published analyses for human cells (28,29), in-
spection of our RNA-seq data showed relative enrichment
of PTBP1/2-specific interaction motifs upstream of the
PTBP1-repressed and downstream of the PTBP1-activated
exons (Supplementary Figure S1A and see Materials and
Methods).
PTBP1-repressed exons tended to be smaller than [me-
dian length 61.5 nt; two-sided Kolmogorov–Smirnov (KS)
test P-value 1.1× 10−16] while PTBP1-activated exons were
statistically indistinguishable (median 126 nt; KS test P-
value 0.78) from their constitutive counterparts (median
120 nt). All regulated exons had relatively weak 5′ and 3′
splice sites (ss) but the 5′ss scores of the activated exons were
significantly lower compared to the repressed ones (P= 7.4
× 10−3; Supplementary Figure S1B andC). Consistent with
this observation, the 5′ss sequences of activated exons often
lacked the canonical AGU suffix in the MAG|GURAGU
consensus sequence known to base pair with the 5′ end
of the spliceosomal snRNA U1 [(53); Supplementary Fig-
ure S1D]. We also analyzed densities of exonic splicing en-
hancer (ESE) and exonic splicing silencer (ESS) motifs but
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did not detect any differences among the corresponding reg-
ulated and non-regulated categories (Supplementary Figure
S2).
The bioinformatically predicted role of PTBP1 in splicing
activation was confirmed for 10 alternative exons that were
shortlisted for RT-PCR validation (Supplementary Figure
S3; also see Dtx2 data below). All these genes had discern-
able PTBP1/2-specific motifs downstream of the regulated
exons (Supplementary Figure S3 and see below). Overall,
these data point at the possibility that activation of mouse
alternative exons by PTBP1 might depend on its recruit-
ment downstream of a suboptimal 5’ss.
Ptbp1 promotes inclusion of the alternative exon 6 in Dtx2
mRNA
To test this prediction, we turned to the PTBP1-activated
exon 6 (e6) of the Dtx2 gene encoding a regulator of the
Notch pathway (54,55) (Figure 1A). This exon has a charac-
teristic for its class length (138 nt; comparable to the 126 nt
median) and a suboptimal 5’ss (AAG|GUAGUU) followed
by putative PTBP1 interaction sites (Figure 1A). We vali-
dated PTBP1 dependence of this exon by treating CAD cells
with a control siRNA (siControl), siPtbp1 or siPtbp1/2 and
analyzing changes in e6 inclusion by RT-PCR (Figure 1B
and Supplementary Figure S4A). Control-treated cells ex-
pressed predominantly the e6-containing form of the Dtx2
mRNA (Figure 1B and C; ‘percent spliced in’ value  =
89%), whereas depletion of PTBP1 alone or together with
PTBP2 reduced e6 inclusion to 37% and 28%, respectively
(ANOVAp-value 2.54× 10−4). e6 splicingwas unaffected in
cells treatedwith siPtbp2 only (Supplementary Figure S4B),
consistent with the relatively low expression of PTBP2 pro-
tein in in the presence of PTBP1 (44,56). Of note, the siR-
NAs used in our experiments had no effect on the overall
Dtx2 mRNA levels (Supplementary Figure S4C).
Ptbp1 is naturally down-regulated by the microRNA
miR-124 in developing neurons, but not in astrocytes
(56,57). We therefore wondered whether Dtx2 e6 was dif-
ferentially spliced in the corresponding cell types. RT-PCR
assays showed that mouse cortical astrocytes expressed pre-
dominantly e6-included Dtx2 transcripts ( = 79%; Fig-
ure 1D). On the other hand, this form was noticeably less
abundant in cortical neuronal progenitor cells (NPCs;  =
17%) and virtually absent in cortical neurons ( = 2%; Fig-
ure 1D). RT-qPCR using PTBP1-specific primers showed a
strong positive correlation between PTBP1 expression levels
and e6 inclusion (Pearson’s correlation coefficient  = 0.98,
P = 7.0 × 10−7; Supplementary Figure S4D). Importantly,
treating NPCs with siPtbp1 or siPtbp1/2 reduced the e6 in-
clusion efficiency 1.8 and 2.5 times, respectively (ANOVA p
value = 1.20 × 10−2; Figure 1E and F and Supplementary
Figure S4E).
To confirm the role of PTBP1 in e6 activation, we as-
sayed splicing of the Dtx2 pre-mRNA fragment spanning
exons e5, e6 and e7 and the two intervening introns in
HeLa nuclear extract (NE) known to contain a substantial
amount of PTBP1 [Figure 1G andH; (33)]. A splicing prod-
uct containing e6 was readily detectable after 1-hour incu-
bation at 30◦C. However, when we repeated the analysis us-
ing a PTBP1-immunodepleted extract, this product failed
to form (Figure 1G andH). The inclusion of e6 was rescued
by the addition of recombinant PTBP1 to the immunode-
pleted NE (Figure 1I and J). We concluded that PTBP1 is
essential for optimal inclusion of the Dtx2 e6 exon.
Inclusion of e6 depends on downstream pyrimidine-rich in-
tronic elements
To find out whether PTBP1 can function as a bona fide
splicing activator, we prepared a doxycycline-inducible
miniDtx2 minigene construct where the Dtx2 e6 in its
natural intronic context was integrated into a recombi-
nant constitutive intron (Figure 2A). CAD cells pretreated
with siControl, siPtbp1 or siPtbp1/2 were transfected with
miniDtx2 and the minigene-specific splicing patterns were
analyzed using RT-PCR with F3/R4 primers (Figure 2B
and C). Regulation of the miniDtx2 transcripts was simi-
lar to that of the endogenous Dtx2 pre-mRNAs, with the
e6 inclusion decreasing from  = 20% in the control to 5%
and 2% in the siPtbp1- and Ptbp1/2- treated samples (Fig-
ure 2B and C).
We mapped cis-elements required for e6 inclusion by pre-
treating CAD cells with siControl, siPtbp1 or siPtbp1/2
and transfecting themwithminiDtx2 variants lacking distal
parts of the Dtx2-derived downstream intron (Supplemen-
tary Figure S5A). Notably, deletion of 210 nt- or 250 nt-
long intronic sequences dramatically reduced e6 inclusion
(Supplementary Figure S5B-C; compare the siControl sam-
ples). On the other hand, minigene lacking only a 150 nt-
long intronic sequence behaved similarly to the full-length
miniDtx2 suggesting that the 50–150 nt sequence window
downstream of the e6 was required for optimal e6 inclusion.
This intronic region contains three evolutionarily con-
served blocks of consensus PTBP1-specificmotifs (Py1, Py2
and Py3; Figure 2A). To address possible contribution of
these elements to e6 splicing, we transfected siRNA-treated
CAD cells with full-length miniDtx2 minigenes contain-
ing corresponding site-specific mutations (Figure 2D). RT-
PCRanalyses showed thatmutating individual Py’s reduced
e6 inclusion with the Py1mut showing the strongest effect.
Combined inactivation of all three Py’s (Py123mut) led to a
complete skipping of e6 even in the siControl samples (Fig-
ure 2D-E).
To test whether PTBP1 directly interacted with the cor-
responding part of the Dtx2 pre-mRNA, we prepared bi-
otinylated RNA fragments containing either the wild-type
(WT) or mutant Py1, Py2 and Py3 sequences and analyzed
recruitment of PTBP1 protein to these ‘baits’ in HeLa NE
using a streptavidin pull-down assay (Supplementary Fig-
ure S6). Immunoblot analyses of the bait-associated mate-
rial revealed relatively efficient interaction of PTBP1 with
the WT probe. Notably, PTBP1 binding was significantly
reduced by inactivating individual Py’s and virtually abol-
ished when the three elements were mutated simultaneously
(Supplementary Figure S6). These data suggest that PTBP1
may promote e6 inclusion by interacting with the Py ele-
ments in the downstream intron.
Suboptimal 5′ splicing site is critical for e6 regulation
To understand its possible functional significance, we
changed the relatively weak 5′ss of e6 to the consensus
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Figure 1. PTBP1 stimulates inclusion of Dtx2 exon 6. (A) A diagram of the mouse Dtx2 gene showing the PTBP1-stimulated exon 6 in its immediate
intronic context. Py1, Py2 and Py3 are downstream elements containing PTBP1 interaction motifs. (B) CAD cells were treated with a PTBP1-specific
siRNA (siPtbp1), a mixture of siPtbp1 and PTBP2-specific siRNA (siPtbp2) or a control non-targeting siRNA (siControl) and the inclusion of the PTBP1-
activated exon 6 (e6) into Dtx2 transcripts was analyzed by RT-PCR. Note that siPtbp1 and siPtbp2 promote e6 skipping. (C) Quantification of the e6-
specific ‘percent spliced in’ ( ) values in (B). (D) An RT-PCR assay showing that Dtx2 e6 is more efficiently included in astrocytes and NPCs than in
neurons. The DIV labels indicate the number of days primary neuronal cultures were maintained in vitro. (E) NPCs were treated with siRNAs as in (B)
and the changes in the Dtx2 splicing pattern were analyzed by RT-PCR. (F) Quantification of the data in (E) showing a significant decrease in e6 inclusion
efficiency in response to siPtbp1 and siPtbp1/2. (G) Splicing of the Dtx2 or the adenovirus major late (AdML) control RNA substrates was assayed in
vitro using either control-treated or PTBP1-depleted nuclear extracts and the reaction products were analyzed by RT-PCR at 0- and 60-min time points.
Note that depletion of PTBP1 inhibits e6 inclusion into Dtx2-derived products but has no effect on the efficiency of AdML splicing. The asterisk marks
an unspecific RT-PCR band visible at both 0 and 60 min. The Dtx2 RNA substrate was produced by in vitro transcription of the DNA fragment amplified
with the EMO4721 and EMO4722 primers (Supplementary Table S4). (H) Difference in the abundance of the e6-containing products between the control
and the PTBP1-depleted 60-min samples quantified from (G). The value in the control sample is set to 1. (I) PTBP1-depleted splicing reactions were
supplemented with indicated amounts of purified recombinant PTBP1 protein and the reaction products were analyzed as in (G). (J) Quantification of the
e6-containing reaction product in (I). The value in the PTBP1-depleted sample is set to 1. Quantitative data in (C, D, F, H and J) are averaged from three
independent experiments ± SD. One-way ANOVA was used in (C, F and J) and a two-tailed t-test assuming unequal variances in (H).
5’ss (5’cons) thus effectively extending its base pairing with
the U1 snRNA (Figure 3A). When introduced into the
miniDtx2 minigene, this mutation transformed e6 into a
constitutive exon that was efficiently included regardless of
the PTBP1 and the PTBP2 expression levels (Figure 3B).
Similar constitutive splicing pattern was observed when we
combined the 5’cons mutation with inactivation of all three
downstream Py sequences (Py123mut) (Figure 3B).
In a reciprocal experiment, we co-transfected the wild-
type miniDtx2 with the U1A4 snRNA expression construct
containing a C4A substitution that was predicted to im-
prove U1 base pairing with the natural e6 5′ss (Figure 3C
and Supplementary Figure S7A). This stimulated e6 inclu-
sion significantly compared to an empty vector or an ex-
pression construct encoding a wild-type U1 snRNA (Fig-
ure 3D and E). The increase in the relative abundance of
the e6-containing splice form in the U1A4 samples was less
pronounced than in the case of miniDtx2–5′cons, consis-
tent with some mismatches remaining in the U1A4/5′ss du-
plex (Figure 3C). Thus, a suboptimal interaction between
U1 snRNA and the 5′ss of e6 is critical for proper regula-
tion of this exon by PTBP1.
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Figure 2. Inclusion of e6 requires downstream pyrimidine-rich sequences. (A) TRE promoter-driven minigene construct (miniDtx2) with the Dtx2 e6
and its flanking intronic sequences embedded within a recombinant exon-intron-exon unit. Downstream intronic pyrimidine-rich sequences (Py1–3) are
depicted as red boxes and their sequences in mouse and several other mammalian species are shown below. (B) CAD cells pretreated with the siControl,
siPtbp1 or siPtbp1/2 were transfected with miniDtx2 and the minigene-specific splicing patterns were analyzed by RT-PCR using the F3/R4 primer pair.
Note that the e6-containing minigene transcripts are readily detectable in the siControl sample but are progressively down-regulated upon PTBP1 and
PTBP2 knockdown. (C) Quantitation of e6 inclusion in (B). (D) CAD cells pretreated with the indicated siRNAs were transfected with either the wild-type
(WT) miniDtx2 construct or its derivatives with mutated Py elements (Py1mut, Py2mut, Py3mut or Py123mut, respectively) and analyzed by RT-PCR as
in (B). Note that the loss of individual Py elements reduces e6 inclusion (especially evident in the siControl samples) and simultaneous inactivation of all
three Py’s renders the e6-containing splice form virtually undetectable. (E) Quantitation of e6-specific  values in (D). The  values in (C) and (E) are
averaged from three independent experiments ± SD and compared using one-way ANOVA.
Activation of e6 depends on interaction between PTBP1 and
U1
Ptbp1 has been shown to contact the U1 stem-loop 4 (SL4)
in the context of splicing repression (58). This hinders the
assembly of a functional spliceosome on the SRC/c-src pre-
mRNA giving rise to non-productive RNP complexes (58).
We wondered if in the case of the Dtx2 pre-mRNA the in-
teraction between PTBP1 and U1 snRNP could stimulate
e6 inclusion by promoting U1 recruitment to the weak 5’ss.
To examine this possibility, we modulated the strength of
the U1-PTBP1 interaction by introducing corresponding
changes to the SL4 element in the U1A4 suppressor. The
interaction was strengthened in the U1A4-SL4-M10 con-
struct (Figure 3C) by substituting several G/C base pairs
in the SL4 stem with A/Us (59). Conversely, the U1A4-
SL4-Dm construct (Figure 3C) contained the Drosophila
melanogaster SL4 interacting with PTBP1 less efficiently
than its mammalian counterpart (59). Gratifyingly, co-
expressing U1A4-SL4-M10 with the wild-type miniDtx2
minigene significantly promoted and U1A4-SL4-Dm re-
duced e6 inclusion e6 inclusion compared to U1A4 (Figure
3D and E). This effect relied on the presence of the down-
stream Py elements since we did not detect any difference in
the minute amounts of the e6-containing isoform produced
from Py123mut miniDtx2 co-transfected with the U1A4,
U1A4-SL4-M10 and U1A4-SL4-Dm (Supplementary Fig-
ure S7B and C).
Of note, the inclusion of e6 into the wild-type miniDtx2
transcripts was less responsive to PTBP1/2 expression lev-
els in the presence of U1A4-SL4-Dm as compared to
U1A4-SL4-M10 (Figure 3F-G). Simultaneous knockdown
of PTBP1 and PTBP2 led to a ∼4.0-fold decrease in e6 in-
clusion in the U1A4-SL4-M10 samples and only a ∼2.5-
fold decrease in the U1A4-SL4-Dm samples (t-test, P =
0.018; Figure 3G). This difference depended on the Py’s
since co-transfection of U1A4-SL4-M10 or U1A4-SL4-
Dmwith miniDtx2-Py123mut gave rise to indistinguishable
splicing patterns (Supplementary Figure S7D-F). These re-
sults indicated that PTBP1 may promote U1 recruitment to
a suboptimal 5′ss in a splicing activation context.
Ptbp1 promotes U1 recruitment to the e6 5’ss
As a direct test of this model, we incubated a biotinylated
RNA fragment containing Dtx2 e6 in its natural intronic
context (WT) with HeLa NE, and purified factors interact-
ing with this ‘bait’ using streptavidin beads (Figure 4A). Im-
munoblot analyses of the bait-associated material showed
that theWTbait efficiently recruited PTBP1 and an integral
U1 snRNP component, U1-70K (Figure 4B and C). U1-
70K failed to interact with a 5’ss-inactivated (5’mut) version
of the bait while PTBP1 binding to this RNAmolecule was
not affected. Importantly, mutations of the downstream Py
elements diminished recruitment of PTBP1 and U1–70K in
a concomitant manner (Figure 4B-C and Supplementary
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Figure 3. Inclusion of e6 depends on interaction between PTBP1 andU1. (A) Base pairing between cell-encodedU1 snRNA and either the wild-type e6 5’ss
(miniDtx2-WT) or its genetically improved version matching the 5’ss consensus sequence (miniDtx2–5’cons). Mutated miniDtx2 nucleotides are shown in
red. (B) CAD cells pretreated with siControl, siPtbp1 or siPtbp1/2 were transfected with miniDtx2-WT, miniDtx2–5’cons or miniDtx2–5’cons-Py123mut
(a derivative of miniDtx2–5’cons additionally lacking the three downstream Py elements) and the minigene-specific splicing patterns were analyzed by
RT-PCR with the F3/R4 primers. Note that 5’cons transforms e6 into a constitutive exon included regardless of the PTBP1 and PTBP2 levels and the
presence of the Py’s. (C) Base pairing between the miniDtx2-WT transcripts and four recombinant U1 snRNAs: a wild-type version (U1WT), its C4A-
mutant (U1A4) and two U1A4 derivatives with modifications in the SL4 stem-loop (U1A4-SL4-M10 and U1A4-SL4-Dm) predicted to strengthen and
weaken PTBP1 binding, respectively. The modified parts of U1 are shown in red. (D) CAD cells were co-transfected with the miniDtx2-WT minigene
and either an expression construct encoding a recombinant U1 snRNA (U1WT, U1A4, U1A4-SL4-M10 or U1A4-SL4-Dm) or the corresponding empty
vector (mock) and analyzed by RT-PCR as in (B). Note that U1A4 promotes e6 inclusion compared to U1WT and the mock. The addition of the SL4-
M10 mutation to the U1A4 background enhances this stimulatory effect whereas SL4-Dm reduces it significantly. (E) e6  values quantified from (D). (F)
CAD cells pretreated with the indicated siRNAs were co-transfected with miniDtx2-WT and either U1A4-SL4-M10 or U1A4-SL4-Dm and analyzed by
RT-PCR as in (B). (G) The repressive effect of PTBP1/2 knockdown on e6 inclusion was calculated by comparing the  values between the corresponding
siPtbp1/2 and siControl samples in (F) as fold down-regulation. Note that e6 is more sensitive to PTBP1/2 levels in the case of U1A4-SL4-M10 compared
to U1A4-SL4-Dm, consistent with the SL4 properties in these two snRNAs. Quantitative data in (E-G) are averaged from three independent experiments
±SD. Samples in (E and G) are compared by a two-tailed t-test assuming unequal variances.
Figure S8).U1-70Kwas an adequate proxy for the entireU1
snRNP complex since RT-qPCR using U1 snRNA-specific
primers detected similar differences in interaction efficien-
cies among the three baits (Figure 4D).
The U1 snRNP recruitment to the WT bait required
PTBP1 protein since incubating the wild-type bait with
a PTBP1-immunodepleted extract significantly decreased
U1-70K and U1 snRNA pull-down efficiencies (Figure 4E–
G). The addition of purified recombinant PTBP1 back to
the immunodepleted extracts rescued U1 snRNP binding
completely (Figure 4E–G). As expected, U1 snRNP bind-
ing to the 5’cons-Py123mut bait containing the consensus
5’ss and no Py’s did not depend on PTBP1 (Figure 4H–J).
We used an RNase H protection assay (Figure 5A) to en-
sure that U1 snRNP formed proper contacts with the e6
5’ss in the above experiments. The addition of RNase H
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Figure 4. Recruitment of U1 snRNP to Dtx2 pre-mRNA depends on PTBP1. (A) A diagram of the pull-down assay. (B–D) Biotinylated RNA baits with
the Dtx2 e6 either in the wild-type intronic context (WT) or containing loss-of-function mutations of the 5’ss (5′mut) or the three Py elements (Py123mut)
were prepared by in vitro transcription of corresponding DNA fragments amplified with the EMO4983 and EMO4782 primers (Supplementary Table
S4). Following a 1-hour incubation with HeLa nuclear, the recruitment of the U1 snRNP and the PTBP1 protein to the baits was analyzed by (B and C)
immunoblotting with U1-70K and PTBP1-specific antibodies or (D) RT-qPCR with U1 snRNA-specific primers. (B) Unlabeled WT Dtx2 RNA was used
as a negative control (-ve ctrl) and lane loading was estimated by the bait-specific RT-PCR. (C) U1-70K recruitment efficiency to the Dtx2 baits in (B)
quantified by band densitometry. Note that association of U1 snRNP with the bait requires PTBP1 binding but not vice versa. (E–G) Biotinylated WT
Dtx2 RNA was incubated with either control-treated or PTBP1-immunodepeleted nuclear extract with or without the addition of purified recombinant
PTBP1 protein (2 g per 250 g of NE) and the recruitment of U1 snRNP and PTBP1 was analyzed as in (B–D). Note that U1 fails to form a stable
complex with the bait in the PTBP1-depleted extract and that recombinant PTBP1 rescues this effect. (H–J) Comparison of the U1 snRNP and the PTBP1
binding properties between the WT bait and its derivative containing the consensus 5’ss and no Py elements (5’cons-Py123mut) carried out as described in
(B–D). Note that U1 snRNP interacts with 5’cons-Py123mut in a PTBP1-independent manner, as expected. Quantitative data in (C, D, F, G, I and J) are
averaged from three independent experiments ± SD and compared by a two-tailed t-test assuming unequal variances.
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Figure 5. PTBP1 recruits U1 snRNP to the e6 5’ss. (A) Diagram of the RNase H protection assay. (B) 32P-labeled WT probes designed as in Figure 4 were
incubated with either control-treated or PTBP1-depleted NE, the indicated oligonucleotides, and RNase H and the reaction products were analyzed by
polyacrylamide gel electrophoresis under denaturing conditions. Note that a U1 snRNP-specific protection signal is present in the control but PTBP1-
depleted samples. Only the 5′-terminal ‘unprotected’ RNA fragment is visible in this experiment possibly because it is capped and therefore more stable
than the 3-terminal fragment.
and a 5’ss-complementary DNA oligonucleotide induced
site-specific cleavage of the WT RNA pre-incubated with
a control-treated HeLa NE; however, a readily detectable
fraction of the substrate remained intact (Figure 5B). This
was due to protection of the 5’ss by U1 snRNP since the
uncut species disappeared when we repeated the experiment
in the presence of a 2’OMe oligonucleotide complementary
to the 5’ss-interacting U1 sequence. Notably, virtually no
protection was observed when the experiment was repeated
using a PTBP1-depleted NE (Figure 5B) or when the WT
bait was substituted with its Py123mut counterpart (Sup-
plementary Figure S9). Together, these data suggested that
PTBP1 promotes physical recruitment of U1 snRNA to the
e6 5’ss.
A context-specific mechanism controls the choice between
splicing activation and repression
Why does interaction between PTBP1 with U1 stimulate
Dtx2 e6 while promoting the assembly of a non-productive
splicing complex on the SRC pre-mRNA (58)? In the latter
case, PTBP1 is known to interact with intronic pyrimidine-
rich elements located both upstream and downstream of the
regulated exon N1 (60). On the other hand, there are 11
consensus PTBP1 binding motifs (YUCUUY, YUCUCY,
YUUCUY and YCUCUY) in a 125 nt intronic window
following Dtx2 e6 and none in the similarly sized sequence
preceding this exon (Figures 1A and 2A). Thus, the oppo-
site outcomes of PTBP1-dependent U1 recruitment in these
two systems might depend on whether PTBP1 binds both
upstream and downstream or downstream only, consistent
with an earlier observation (28).
To address this possibility, we replaced the natural in-
tronic sequence immediately preceding Dtx2 e6 with the
corresponding SRC sequence previously shown to recruit
PTBP1 (36,60). When we introduced this modification to
the wild-type miniDtx2 minigene e6 became constitutively
skipped regardless of the PTBP1 and PTBP2 expression lev-
els (not shown). To facilitate further analyses, we slightly
enhanced the natural e6 5’ss by substituting the G at the +4
position with an A. This improved base pairing between the
5’ss and the wild-type U1 snRNA, albeit to a level that was
still suboptimal compared to the 5’ss consensus. Indeed, the
modified minigene (miniDtx2–5’G4A) retained the e6 de-
pendence on PTBP1 (Figure 6A and B).
Notably, swapping the natural upstream intronic se-
quence for its SRC N1 counterpart in this background
(miniDtx2–5’G4A-upSrc) converted e6 into a PTBP1-
repressible exon (Figure 6A and B and Supplementary Fig-
ure S11A). The SRC-derived sequence was sufficient for
PTBP1-dependent repression in the absence of the Dtx2-
specific downstream Py elements (Figure 6A and B). How-
ever, the overall extent of e6 repression was substantially
lower in this case (miniDtx2-5’G4A-upSrc-Py123mut) than
for miniDtx2-5’G4A-upSrc (Supplementary Figure S10).
Similar results were obtained when we inserted the SRC
PTBP1-binding sequence in front of the e6-specific branch
point sequence and kept the natural Dtx2 3’ss region intact
(miniDtx2-5’G4A-up2Src and miniDtx2–5’G4A-up2Src-
Py123mut minigenes; Supplementary Figure S11A–C).
To understand themechanismunderlying the switch from
activation to repression, we examined recruitment of U1
and U2 snRNPs to biotinylated RNA probes containing
e6 in the 5’G4A, 5’G4A-upSrc or 5’G4A-upSrc-Py123mut
contexts corresponding to the above minigenes. U1 inter-
acted with the 5’G4A and 5’G4A-upSrc RNAs compara-
bly well arguing that PTBP1 binding upstream of e6 does
not interfere with this step of the spliceosome assembly
(Figure 6C). In both cases U1 was recruited to its correct
5’ss position (Figure 6D). U1 recruitment to 5’G4A-upSrc-
Py123mutwas substantially less efficient (Figure 6C andD).
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Figure 6. PTBP1 binding both upstream and downstream of e6 leads to a strong repression effect accompanied by the assembly of a splicing-deficient
ribonucleoprotein complex. (A) CAD cells pretreated with siControl, siPtbp1 or siPtbp1/2 siRNAs were transfected with 5′G4A-modified miniDtx2
minigenes showing a more efficient inclusion of e6 compared to the miniDtx2-WT but (unlike miniDtx2–5′cons in Figure 3B) remaining responsive to the
PTBP1 and PTBP2 levels. Three such minigenes were used: miniDtx2–5′G4A containing no additional changes, miniDtx2–5′G4A-upSrc containing an
upstream PTBP1-interacting intronic sequence from the human SRC gene, andminiDtx2–5′G4A-upSrc-Py123mut containing the upstream SRC sequence
but no downstreamDtx2 Py elements. Analysis of the minigene-specific splicing patterns by RT-PCR with the F3/R4 primer pair showed that PTBP1 and
PTBP2 stimulate e6 inclusion in the miniDtx2–5′G4A transcripts and that this effect is inverted for miniDtx2–5′G4A-upSrc and miniDtx2–5′G4A-upSrc-
Py123mut. Importantly, e6 is repressed in the miniDtx2–5′G4A-upSrc context to a substantially greater extent than in miniDtx2–5′G4A-upSrc-Py123mut,
which is especially obvious in the siControl samples. (B) Quantitation of e6 inclusion efficiency in (A). (C) Recruitment ofU1 andU2 snRNPs to biotinylated
RNA baits designed as explained in Figure 4 and matching the minigene sequences in (A-B) was analyzed in the corresponding pull-down fractions by
RT-qPCR with snRNA-specific primer pairs. Note that miniDtx2–5′G4A interacts well with both U1 and U2 snRNPs whereas miniDtx2–5′G4A-upSrc-
Py123mut recruits these snRNPs inefficiently. The addition of the upSrc element to miniDtx2–5′G4A diminishes its ability to recruit U2 but does not
compromise U1 binding. Quantitative data in (B-C) are averaged from 3 independent experiments ± SD. (D) RNase H protection assay confirming that
miniDtx2–5′G4A and miniDtx2-5′G4A-upSrc but not miniDtx2–5′G4A-upSrc-Py123mut allow U1 to form a stable complex with the e6 5’ss.
On the other hand, U2 interacted well only with the 5’G4A
but not the 5’G4A-upSrc or the 5’G4A-upSrc-Py123mut
RNAs (Figure 6C). Similar U1 and U2 recruitment pat-
terns were detected for the up2Src transcripts (Supplemen-
tary Figure S11D). Thus, recruitment of PTBP1 both up-
stream and downstream of e6 leads to a strong repression
effect accompanied by the assembly of a splicing-deficient
exonic complex containing U1 but no U2 snRNP.
PTBP1-facilitated recruitment of U1 to the 5’ss is a general
phenomenon
We finally asked whether facilitated recruitment of the
U1 snRNP to the 5’ss could be a common mechanism
for PTBP1-stimulated exon inclusion. To this end, we re-
placed most of the Dtx2 e6 with a SRC N1 sequence in
the miniDtx2-5’G4A background (Supplementary Figure
S12A) and assayed PTBP1 dependence of the resultant
miniDtx2(SrcN1)-G4A minigene in CAD cells. Consistent
with the presence Dtx2-specific intronic sequences in this
construct, the inclusion of the recombinant exon was stim-
ulated by PTBP1 (Supplementary Figure S12B). Our ad-
ditional pull-down assays showed that PTBP1 was also re-
quired for efficient U1 recruitment to the biotinylated RNA
bait corresponding to miniDtx2(SrcN1)-G4A and contain-
ing the recombinant exon in in its immediate intronic con-
text (Supplementary Figure S12C).
We also repeated the pull-down experiment using bi-
otinylated RNAs comprising the natural PTBP1-dependent
cassette exons from the Eml4, Flnc and Scarb1 genes in
their natural intronic contexts (see Supplementary Figure
S3). Similar to the wild-type Dtx2 and the recombinant
miniDtx2(SrcN1)-G4A-derived baits above, U1 snRNP
was efficiently recruited to all three of these RNAs in un-
treated nuclear extract (Figure 7A and B). The recruitment
was impaired by PTBP1 immunodepletion and rescued by
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Figure 7. Augmented recruitment of U1 is a general mechanism for splicing activation by PTBP1. (A–C) Pull-down experiments were carried as outlined
in Figure 4E–G using RNA baits containing 5’ss-adjacent sequences from the PTBP1-stimulated cassette exons from the Eml4, Flnc and Scarb1 genes.
(A) Immunoblot analysis with U1-70K and PTBP1-specific antibodies, (B) immunoblot quantitation and (C) RT-qPCR analysis of the U1 recruitment
efficiency suggest that all three probes form stable complexes with U1 only in the presence of bound PTBP1. Data in (B and C) are quantified from 3
independent experiments ±SD and compared by a two-tailed t-test assuming unequal variances. (D) A mechanistic model for the choice between PTBP1-
mediated activation and repression of alternative exons.
the addition of purified PTBP1 back to the immunode-
pleted extract (Figure 7A and B). All in all, these data ar-
gue for generality of PTBP1-stimulated U1 recruitment as
a splicing activation mechanism.
DISCUSSION
The choice between inclusion and skipping of alternative
exons involves integration of positive and negative inputs
from trans-acting protein factors interacting with splicing
enhancer and silencer elements. Mounting evidence sug-
gests that many individual RBPs can function as either ac-
tivators or repressors of splicing depending on their pre-
mRNAbinding position. Yet, how such positional informa-
tion is decoded at the molecular level remains an open ques-
tion. Here we identify a mechanism allowing PTBP1, an
important post-transcriptional regulator with extensively
characterized splicing repressor activities, to function as a
bona fide activator of alternative exons.
We show that PTBP1 promotes inclusion of a cassette
exon by interacting with downstream intronic pyrimidine-
rich elements and facilitating productive recruitment of U1
snRNA to a suboptimal 5’ss (Figures 2D and E, 4, 5 and
Supplementary Figure S8). This appears to be a general
mechanism since PTBP1 is essential for efficient interac-
tion of U1 with at least four natural and one recombi-
nant pre-mRNA regulated in this manner (Figures 4, 7A-
C and Supplementary Figure S12). These results are con-
sistent with earlier studies that proposed that PTBP1 might
stimulate cassette exons and alternative 5’ss directly without
describing the underlying molecular mechanisms (28,33).
Combined with evidence for an indirect mechanism used
by PTBP1 to activate some alternative exons (25), our data
suggest that the molecular effects of PTBP1 on pre-mRNA
splicing are more diverse than previously thought.
Ptbp1 recruitment to a downstream intronic position was
previously shown to facilitate repression of the SRC cassette
exon N1 by forming physical contacts with the stem-loop
element SL4 in the U1 snRNA (58). In that case, PTBP1 al-
tered the U1 snRNP interaction footprint on the N1 5’ss
and interfered with the assembly of a functional spliceo-
some (58). Our experiments with SL4 mutants known to
strengthen (M10) or weaken (Dm) association of U1 with
PTBP1 on the SRC pre-mRNA suggest that a similar in-
teraction mechanism is likely used in the case of PTBP1-
activated exons (Figure 3). This argues that interaction of
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PTBP1 with U1 is not an inherently repressive event and
other mechanisms must determine the choice between the
two opposite functional outcomes.
Since PTBP1-activated exons have significantly weaker
5’ss than their PTBP1-repressed counterparts, both in hu-
man (28) and mouse (Supplementary Figure S1B), one may
hypothesize that the choice between repression and activa-
tion is determined by the degree of base paring between U1
and this element. Consistent with this possibility, splicing
effects of hnRNPs L, a PTBP1-related protein, are known
to be modulated by the 5’ss strength (61). Moreover, hn-
RNPs L and hnRNP A1 have been previously shown to re-
press some exons by extending contacts between U1 and
the 5’ss and thus effectively blocking subsequent spliceo-
some maturation steps (62). However, strengthening U1 in-
teraction with the 5’ss in the Dtx2 e6 context consistently
enhanced inclusion of this exon in the presence of PTBP1
rather than promoting its skipping (Figure 3B). Thus, pos-
sible ‘hyper-stabilization’ of the U1/pre-mRNA complex
cannot explain the switch from activation to repression in
the case of PTBP1.
That said, at least two lines of evidence argue that the 5’ss
has to be relatively weak to enable PTBP1-mediated splicing
activation. (1) Substitution of the natural 5’ss with its con-
sensus version in Dtx2 e6, used as our main experimental
model, leads to constitutive inclusion of this exon in mouse
cells (Figure 2A and B). (2) Efficient recruitment of U1 to
the consensus 5’ss in vitro does not require PTBP1, unlike
the situation with the natural Dtx2 e6 5’ss (Figure 4H–J).
However, more subtle improvements in the base pairing be-
tweenU1 and the 5’ss do not abolish the regulation pointing
at its relative robustness (Figures 3F and 6A and B).
Many PTBP1-repressed exons including the SRC N1
contain both upstream and downstream PTBP1 binding el-
ements (34,35,60). When we recapitulated this arrangement
by adding the SRC-derived upstream PTBP1-interacting
sequence to a Dtx2 e6-containing minigene containing
the natural downstream Py elements, the behavior of e6
changed from PTBP1 activation to repression (Figure 6A-
B and Supplementary Figure S11B and C). A similar effect
has been observed earlier for another cassette exon natu-
rally stimulated by PTBP1 (28).
Our data shed some light onmolecular details underlying
this functional switch. We show that upstream PTBP1 in-
teraction sequences do not compromise PTBP1-facilitated
recruitment of U1 but instead hinder U2 binding (Figure
6C and D and Supplementary Figure S11D). This result
is generally consistent with previously published functional
data (23) and biochemical analyses of a recombinant exon
flanked by PTBP1-binding sequences (40). Of note, the e6
inclusion efficiency in the upSrc-Py123mut and the up2Src-
Py123mut transcripts containing only upstream PTBP1-
binding elements is substantially higher compared to their
upSrc and up2Src counterparts where such elements are lo-
cated both upstream and downstream of the regulated exon
(Figure 6C and D, Supplementary Figures S10 and S11D).
This is somewhat surprising given that U1 interacts with
upSrc-Py123mut and up2Src-Py123mut significantly worse
than with upSrc and up2Src (Figure 6C and D and Supple-
mentary Figure S11D).
A model emerging from these results is summarized in
Figure 7D. In the absence of other regulatory interactions,
PTBP1 recruited downstream of an alternative exon stim-
ulates its inclusion by stabilizing productive U1 docking to
the 5’ss. Exclusive recruitment of PTBP1 upstream of the
exon can promote its skipping, at least in part by antago-
nizing U2 binding to the upstream branch point. Finally,
binding of PTBP1 on both sides of a regulated exon is capa-
ble of inducing a strong repressive effect that might involve
assembly of an aberrant exon definition complex.
Although additional work will obviously be required to
explore the latter possibility, PTBP1 binding to intronic
sequences flanking an alternative exon has been recently
shown to interfere with normal exon definition by allow-
ing recruitment of the U1 but not the U2 snRNP (40).
The overall composition of proteins interacting with the
exon repressed in this manner differs markedly from that of
the normally defined exon (40). Therefore, the non-additive
outcome of combining the upstream and the downstream
PTBP1 sequences in the upSrc and up2Src minigenes (Fig-
ure 6, Supplementary Figures S10 and S11) might be medi-
ated by sequestering e6 in a non-productive ribonucleopro-
tein complex that effectively competes with proper defini-
tion of this exon. This will be an interesting line of research
to pursue in the future, especially given the increasing ap-
preciation of ‘trapped’ states in the spliceosome assembly
and the roles they play in splicing regulation (40,62–64).
In addition to PTBP1, several other RBPs have been
shown to either activate or repress splicing by forming con-
tacts with U1 snRNP in the vicinity of their binding sites
(62,65–69). Our study extends this line of research by show-
ing that the functional consequence of such contacts can
be modulated to a remarkable degree by additional inter-
actions of the same RBP with its pre-mRNA target. This
argues that the information encoded by individual RBP
binding events is fundamentally insufficient for instruct-
ing the ultimate splicing decisions and the exactly same
RNA element may function as an enhancer or silencer de-
pending on a wider sequence context. If so, considering
possible crosstalk between interaction sites in a systematic
manner should substantially enhance the power of future
knowledge-basedmodels aiming to predict splicing changes
that occur in response to disease-associated mutations or as
a result of evolution.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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